Biotronik said today that it launched its Itrevia MRI-safe quad cardiac resynchronization therapy defibrillator in Japan, part of a Japanese rollout of new devices for 2015. The device is equipped with home monitoring connectivity, as well as compatibility with up to 1.5 tesla MRI machines, the German medical device giant said. “As a producer of superior […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Toshiba, Merge ink partnership deal
Merge Healthcare (NSDQ:MRGE) said yesterday it formed a strategic partnership with Toshiba Medical Systems (TYO:6502) to offer both companies products together as a turnkey solution for customers. The companies will partner to offer Merge’s cardiology PACS and hemodynamic monitoring with the Toshiba vascular x-ray systems, Chicago, Ill.-based Merge Healthcare said. “For more than 15 years, the Toshiba […]
St. Jude Medical launches OCT stenting trial
St. Jude Medical (NYSE:STJ) today said it’s launching the 1st trial comparing optical coherence tomography device with intravascular ultrasound or angiography during stenting procedures. St. Paul, Minn.-based St. Jude said the 420-patient Ilumien III trial will compare treatment with its Optis Integrated and Ilumien Optis percutaneous coronary intervention optimization systems in treating patients with stable or unstable angina, silent ischemia or […]
UPDATE: Medical societies update stroke guidelines
A bevy of cardiac medical societies updated their guidelines for stroke treatment yesterday to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices. The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions have updated their guidelines to include the benefits of left […]
AHA/ASA updates stroke treatment guidelines
The American Heart Association/American Stroke Association said today that it updated its treatment guidelines for patients suffering from ischemic stroke to include endovascular treatments. The decision supports the use of stent retrieval, and other thrombectomy devices, used to remove clots in patients who have obstructions in the large arteries supplying blood to the brain according […]
DoJ closes Abiomed Impella 2.5 investigation
Abiomed (NSDQ:ABMD) said today that the U.S. Department of Justice has closed an investigation into the marketing of the company’s Impella 2.5 heart pump without taking any enforcement action. The investigation began in October 2012 when Danvers, Mass.-based Abiomed said it was informed that the U.S. Attorney’s Office of the District of Columbia had initiated […]
TAVI: Medtronic wins patent spat with doc inventor
Medtronic (NYSE:MDT) last week won a patent infringement dispute over its CoreValve aortic valve replacement with inventor Dr. Troy Norred, according to legal filings. The U.S. Patent & Trademark Office’s Patent Trial & Appeals Board found that 16 of Norred’s claims were unpatentable, upholding Medtronic’s challenge to the patent, PTO records show. The patent board ruled that […]
SentreHeart wins FDA nod for Lariat trial
SentreHeart said yesterday it won FDA investigational device exemption approval to begin enrolling subjects in a clinical trial of its Lariat device. The Amaze trial will evaluate the use of the Lariat for the ligation of the left atrial appendage as an adjunctive treatment to ablation in patients with persistent atrial fibrillation, the company said. “The […]
Medtronic wins FDA nod, launches Advisa SR MRI-safe pacer
Medtronic (NYSE:MDT) said today that it won FDA approval for its Advisa SR MRI-safe SureScan single-chamber pacemaker, and that it is launching the device in the U.S. The device will allow MRI scans of any region of the body as long as it is used with MRI-safe SureScan leads, the Fridley, Minn.-based company said. “MRI is […]
Cardiac Dimensions launches clinical trial for Carillon mitral valve device
Cardiac Dimensions today said it launched a clinical trial of its Carillon device, which is designed to treat functional mitral valve regurgitation. The 120-patient Reduce FMR study is a prospective, double-blind, randomized multi-center trial, Kirkland, Wash.-based Cardiac Dimensions said. Patients are slated to be randomized on a 3:1 basis to receive the Carillon device and optimal drug […]
Sorin touts Freedom Solo aortic valve data
Sorin Group (BIT:SRN) said today that data from a 1-year study of its Freedom Solo stentless pericardial aortic valve showed positive safety and efficacy results. The 251-patient study looked at individuals in North America with aortic valve disease who are implanted with the device, the Milan, Italy-based company said. Results showed a mean reduction in gradient […]